Index
RUT
Market Cap
192.67M
Enterprise Value
101.62M
Income
-24.59M
Sales
354.30M
Book/sh
6.54
Cash/sh
4.03
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
753
IPO
Feb 14, 2014
P/E
-
Forward P/E
-
PEG
-
P/S
0.54
P/B
1.11
P/C
1.80
P/FCF
-
EV/EBITDA
-
EV/Sales
0.29
Quick Ratio
2.34
Current Ratio
2.74
Debt/Eq
0.09
LT Debt/Eq
0.07
Option/Short
Yes / Yes
EPS (ttm)
-0.90
EPS next Y
-0.48
EPS next Q
-0.14
EPS this Y
11.17%
EPS next Y
37.58%
EPS next 5Y
32.01%
EPS past 3/5Y
38.44% -26.38%
Sales past 3/5Y
-2.59% 2.48%
EPS Y/Y TTM
14.61%
Sales Y/Y TTM
3.15%
EPS Q/Q
7.53%
Sales Q/Q
3.04%
Insider Own
3.70%
Insider Trans
-2.16%
Inst Own
73.09%
Inst Trans
0.46%
ROA
-8.23%
ROE
-13.14%
ROIC
-13.12%
Gross Margin
51.66%
Oper. Margin
-8.39%
Profit Margin
-6.94%
SMA20
11.84%
SMA50
24.96%
SMA200
16.67%
Trades
Shs Outstand
26.73M
Shs Float
25.56M
52W High
8.69 -16.46%
52W Low
5.05 43.90%
Volatility
3.32% 4.03%
ATR (14)
0.22
RSI (14)
77.54
Beta
1.58
Rel Volume
0.85
Avg Volume
302.80K
Volume
257,605
Perf Week
3.12%
Perf Month
37.76%
Perf Quarter
12.56%
Perf Half Y
2.11%
Perf YTD
8.04%
Perf Year
-13.67%
Perf 3Y
72.45%
Perf 5Y
-81.69%
Perf 10Y
-86.41%
Prev Close
7.25
Price
7.26
Change %
0.14%
Analysts 8 incl. previous ratings
Rating Distribution 4 Buy · 4 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Jun 16, 2025 Initiated R B. Riley Securities
Buy $14 +92.8% May 22, 2025 Upgrade N Needham
Hold → Buy $12 +65.3% Feb 15, 2024 Upgrade W William Blair
Mkt Perform → Outperform Aug 08, 2023 Downgrade J JP Morgan
Overweight → Neutral $15 → $8 +10.2% Jul 14, 2023 Downgrade N Needham
Buy → Hold Jan 17, 2023 Downgrade W William Blair
Outperform → Mkt Perform Dec 09, 2021 Upgrade N Needham
Hold → Buy $47 +547.4% Nov 02, 2021 Upgrade J JP Morgan
Underweight → Neutral $45 +519.8% Aug 05, 2021 Downgrade K KeyBanc Capital Markets
Overweight → Sector Weight Jun 04, 2021 Upgrade W William Blair
Mkt Perform → Outperform Dec 14, 2020 Upgrade K KeyBanc Capital Markets
Sector Weight → Overweight $60 +726.4% Jul 23, 2020 Downgrade N Needham
Buy → Hold May 06, 2020 Reiterated N Needham
Buy $80 → $75 +933.1% Nov 06, 2019 Upgrade N Needham
Hold → Buy $90 +1,139.7% Sep 13, 2019 Reiterated P Piper Jaffray
Overweight $80 → $80 +1,001.9% Aug 08, 2019 Downgrade S SVB Leerink
Outperform → Mkt Perform $78 → $47 +547.4% Aug 08, 2019 Downgrade S Stifel
Buy → Hold Aug 07, 2019 Downgrade N Needham
Buy → Hold Jun 28, 2019 Downgrade N Needham
Strong Buy → Buy $111 → $91 +1,153.4% May 08, 2019 Reiterated N Needham
Strong Buy $191 → $111 +1,428.9%
Show Previous Ratings
Oct-28-26 08:06PM
Oct-15-26 01:00PM
Oct-01-26 07:58AM
(Medical Device Network)
+13.47%
Sep-30-26 04:05PM
Sep-28-26 12:49PM
01:04AM
Loading…
Aug-07-26 01:04AM
Aug-06-26 04:50PM
04:05PM
Jul-16-26 08:30AM
May-07-26 05:13PM
04:05PM
Apr-23-26 08:30AM
Apr-08-26 08:01PM
Apr-06-26 04:00PM
Mar-30-26 04:05PM
04:00PM
Loading…
04:00PM
Mar-05-26 09:15AM
Feb-25-26 12:49PM
12:08AM
12:01AM
Feb-24-26 07:30PM
04:44PM
(Associated Press Finance)
04:05PM
04:00PM
Feb-23-26 07:25PM
Feb-18-26 10:00AM
Feb-17-26 10:00AM
Feb-11-26 09:22PM
Feb-10-26 09:35AM
Feb-02-26 09:51AM
07:40AM
Loading…
07:40AM
Jan-12-26 08:30AM
Jan-08-26 09:46AM
Jan-07-26 08:30AM
Jan-02-26 08:33AM
Dec-22-25 03:35PM
Dec-19-25 08:41AM
Dec-08-25 08:21AM
Dec-05-25 11:30AM
09:04AM
Nov-14-25 09:35AM
Nov-08-25 10:00AM
Nov-06-25 01:22PM
Nov-05-25 08:50AM
07:47AM
(Associated Press Finance)
07:30AM
Nov-04-25 08:39AM
Oct-15-25 08:30AM
Sep-30-25 08:50AM
Sep-26-25 09:21AM
Sep-25-25 04:05PM
09:24AM
Sep-23-25 08:21AM
Sep-11-25 08:24AM
Sep-08-25 05:04PM
Sep-02-25 10:36AM
Aug-21-25 09:55AM
Aug-12-25 04:42AM
Aug-08-25 12:11PM
03:40AM
Aug-07-25 06:55PM
06:08PM
(Associated Press Finance)
04:05PM
Aug-05-25 06:50PM
Jul-17-25 08:30AM
Jul-16-25 09:42AM
Jun-23-25 08:30AM
Jun-06-25 11:31AM
May-28-25 09:14AM
04:41AM
May-27-25 09:10AM
May-22-25 04:34PM
May-16-25 12:00PM
09:35AM
May-08-25 12:06PM
03:36AM
May-07-25 08:18PM
08:16PM
07:00PM
05:55PM
04:53PM
(Associated Press Finance)
04:05PM
10:00AM
May-06-25 10:13AM
May-01-25 05:45PM
Apr-16-25 08:30AM
07:10AM
Mar-27-25 11:30AM
Mar-20-25 08:30AM
Mar-13-25 09:30AM
Feb-26-25 07:41AM
(Thomson Reuters StreetEvents)
-14.81%
02:17AM
Feb-25-25 05:55PM
05:02PM
(Associated Press Finance)
04:05PM
01:51AM
Feb-03-25 04:00PM
Jan-26-25 12:00PM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Smith Kevin P. EVP, Bus Dev, GC & Sec Sep 01 '26 Option Exercise 0.00 18,136 0 41,643 Sep 03 05:01 PM Yi Boyer Jennifer M EVP Entrprs Enblmnt, Ch HR Off Jul 01 '26 Sale 6.60 10,938 72,146 5,039 Jul 06 04:36 PM JENNIFER YI BOYER Officer Jul 01 '26 Proposed Sale 6.45 10,938 70,550 Jul 01 04:50 PM Yi Boyer Jennifer M EVP Entrprs Enblmnt, Ch HR Off May 29 '26 Sale 6.53 10,770 70,313 15,977 Jun 02 04:30 PM JENNIFER YI BOYER Officer May 29 '26 Proposed Sale 6.54 10,770 70,436 May 29 04:23 PM Wright Mary E VP, Chief Accounting Officer Mar 01 '26 Option Exercise 0.00 7,506 0 20,284 Mar 03 05:00 PM Yi Boyer Jennifer M EVP Entrprs Enblmnt, Ch HR Off Mar 01 '26 Option Exercise 0.00 25,017 0 33,699 Mar 03 04:59 PM Ramade Gregoire Chief Commercial Officer Mar 01 '26 Option Exercise 0.00 13,005 0 50,251 Mar 03 04:58 PM Smith Kevin P. EVP, Bus Dev, GC & Sec Mar 01 '26 Option Exercise 0.00 14,005 0 28,283 Mar 03 04:57 PM Bourque Michael J. EVP, CFO & Treasurer Mar 01 '26 Option Exercise 0.00 42,007 0 100,949 Mar 03 04:57 PM Smith Kevin Raymond Merrill CEO and President Mar 01 '26 Option Exercise 0.00 58,346 0 147,973 Mar 03 04:56 PM Ramade Gregoire Chief Commercial Officer Dec 01 '25 Option Exercise 0.00 31,566 0 50,189 Dec 02 04:08 PM Smith Kevin Raymond Merrill CEO and President Dec 01 '25 Option Exercise 0.00 28,334 0 100,108 Dec 02 04:06 PM
Inogen, Inc. is a global medical technology company offering innovative respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class respiratory therapy devices used to deliver care to patients suffering from chronic respiratory conditions. Its products include Inogen One G4 system, Inogen One G3 system, Inogen One G5 system, Inogen TAV, and Inogen at Home. The company was founded by Alison Perry, Alison K. Bauerlein, Brenton Taylor, and Byron Myers on November 27, 2001 and is headquartered in Beverly, MA.
President Mr. Kevin R. M. Smith
General Counsel Mr. Kevin P. Smith
Executive VP of Enterprise Enablement & Chief Human Resources Officer Ms. Jennifer Yi Boyer
CFO Mr. Jason A. Richardson
Executive VP & COO Mr. Andrew P. Reding